This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Dongkook Pharmaceutical Co., Ltd.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Deok Keun Lee: Innovator in Pharmaceutical Composition
Introduction
Deok Keun Lee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficacy and convenience of medication administration.
Latest Patents
Deok Keun Lee holds a patent for a pharmaceutical composition for parenteral administration, which contains donepezil as an active ingredient. This invention relates to a composition designed for sustained release, allowing for continuous in vivo release for 2-12 weeks or more. The preparation method involves creating microparticles that comprise a biodegradable and biocompatible polymer along with a release controller. This advancement reduces the frequency of administration required for patients while maintaining effective blood concentration over an extended period.
Career Highlights
Deok Keun Lee is associated with Dongkook Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical innovations. His work has contributed to the development of more effective treatment options for patients, particularly those requiring long-term medication management.
Collaborations
He has collaborated with notable colleagues, including Sung Jin Ko and Shin Eom, to further advance research and development in the pharmaceutical sector.
Conclusion
Deok Keun Lee's contributions to pharmaceutical compositions exemplify the importance of innovation in improving patient care. His work not only enhances the effectiveness of medications but also significantly improves the quality of life for patients requiring long-term treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile